Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Literature DB >> 7016385

Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

L Balant.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1981 PMID： 7016385 DOI： 10.2165/00003088-198106030-00003

Source DB: PubMed Journal: Clin Pharmacokinet ISSN： 0312-5963 Impact factor: 6.447

× No keyword cloud information.

131 in total

Review 1. [Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)].

Authors: J Fabre; L Balant; M Rudhardt; P Blanchard
Journal: Nouv Presse Med Date: 1979 Aug 25-Sep 3

2. Drug interactions and long-term antidiabetic therapy.

Authors: A W Logie; D B Galloway; J C Petrie
Journal: Br J Clin Pharmacol Date: 1976-12 Impact factor: 4.335

Review 3. Insulin secretion: multifactorial regulation for a single process of release. The Minkowski award lecture delivered on September 7, 1972 before the European Association for the study of Diabetes at Madrid, Spain.

Authors: W J Malaisse
Journal: Diabetologia Date: 1973-06 Impact factor: 10.122

4. Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

Authors: S B Matin; S H Wan; J H Karam
Journal: Clin Pharmacol Ther Date: 1974-12 Impact factor: 6.875

5. The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.

Authors: B Hellman; J Sehlin; I B Täljedal
Journal: Diabetologia Date: 1973-06 Impact factor: 10.122

6. Binding of sulfonylureas to serum albumin.

Authors: M J Crooks; K F Brown
Journal: J Pharm Sci Date: 1973-11 Impact factor: 3.534

7. [Resorption, excretion and metabolism after intravenous and oral administration of HB 419-14C in man].

Authors: W Rupp; O Christ; W Heptner
Journal: Arzneimittelforschung Date: 1969-08

8. [Hypoglycemic coma due to antidiabetic sulfonamides. Apropos of 16 cases].

Authors: J P Lauvaux; O Thys; J Sternon
Journal: Acta Clin Belg Date: 1968 Impact factor: 1.264

9. Tolbutamide binding to plasma proteins of young and old human subjects.

Authors: A K Miller; J Adir; R E Vestal
Journal: J Pharm Sci Date: 1978-08 Impact factor: 3.534

10. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.

Authors: A Melander; G Sartor; E Wåhlin; B Scherstén; P O Bitzén
Journal: Br Med J Date: 1978-01-21

23 in total

Review 1. [Cytochrom-P450 mediated drug interactions caused by antibiotics].

Authors: Christiane Thallinger; Christian Joukhadar
Journal: Wien Med Wochenschr Date: 2006-09

Review 2. Guide to drug dosage in renal failure.

Authors: W M Bennett
Journal: Clin Pharmacokinet Date: 1988-11 Impact factor: 6.447

3. Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.

Authors: B J Zünkler; S Lenzen; K Männer; U Panten; G Trube
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1988-02 Impact factor: 3.000

4. Prediction of drug disposition in diabetic patients by means of a physiologically based pharmacokinetic model.

Authors: Jia Li; Hai-Fang Guo; Can Liu; Zeyu Zhong; Li Liu; Xiao-Dong Liu
Journal: Clin Pharmacokinet Date: 2015-02 Impact factor: 6.447

5. Pharmacokinetics of chlorpropamide in epileptic patients: effects of enzyme induction and urine pH on chlorpropamide elimination.

Authors: P J Neuvonen; S Kärkkäinen; R Lehtovaara
Journal: Eur J Clin Pharmacol Date: 1987 Impact factor: 2.953

Review 10. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.

Authors: K J Palmer; R N Brogden
Journal: Drugs Date: 1993-07 Impact factor: 9.546